IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($1.19), $0.34 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $304.78 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.